Nitazene is quietly increasing opioid deaths
The drug is usually consumed accidentally
More deaths can likely be attributed to opioids than previously thought, and that is largely thanks to a substance called nitazene. The synthetic drug can be five to nine times stronger than fentanyl, which is already approximately 25 to 50 times stronger than heroin. Nitazene is often hidden in other products and difficult to test for, so it often goes undetected.
How prevalent is nitazene?
Nitazene was first developed in the 1950s as an analgesic, but was never approved for medical use. Instead, it was “limited to those researching opioid pharmacology,” said Rolling Stone. Nitazene’s presence mostly remained that way until 2019, when the drug emerged on the street market in Europe and the U.S. From there, its presence accelerated. In 2023, 20 different nitazenes were reported by 28 countries to the UN, according to the World Drug Report 2025. Then in 2024, “more new nitazenes than new fentanyl analogs were being reported,” accounting for “almost 50% of all reported opioid NPS (novel psychoactive substances).”
In the U.S., 320 overdose deaths in 2023 reportedly involved nitazenes, according to the World Drug Report. However, this number is likely understated. The country still mostly “relies on toxicology panels built for yesterday’s drug supply,” said Time. The antiquated panels can “reliably identify heroin, oxycodone and fentanyl,” but they “fail to catch nitazenes, brorphine or other new synthetic analogs.” Without proper identification, “policymakers and public health professionals chase outdated trends.” A “person who dies with both cocaine and a nitazene in their system might still be coded as a ‘cocaine death.’”
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Fentanyl is still considered the number one cause of opioid deaths, accounting for 48,422 deaths in the U.S. in 2024. But there have been “reported signs of a declining fentanyl market” within the country, with “declining purity and a smaller number of seizures of fentanyl pills.” The rise in nitazenes “may be a response to efforts to reduce the supply of other opioids,” said Ryan Marino, a toxicologist and expert in addiction medicine at University Hospitals in Cleveland, to Rolling Stone. “In almost every case where nitazenes are found, they are added to other drugs, primarily fentanyl, and not advertised as containing nitazenes when sold.”
How dangerous is it?
Even very small doses of nitazene can be deadly. The lethality of fentanyl is “anywhere between 10 and 20 grains of salt,” said Frank Tarentino, the special agent in charge of the Drug Enforcement Administration’s New York lab, to CBS News. With nitazene, “we're talking about anywhere from one grain or less.” Much of the exposure to nitazene comes inadvertently. It has been found in “vapes sold as containing cannabis, in pills shaped as teddy bears supposed to be MDMA, in powder trafficked as cocaine, in counterfeit pain medication,” said The Guardian.
Synthetic opioids are so dangerous that first responders have to avoid inhalation when addressing an overdose situation. The drugs “slow down the part of your brain that tells you to breathe,” said Dimitri Gerostamoulos, an associate professor and the chief toxicologist at the Victorian Institute of Forensic Medicine, to The Guardian. “This is what causes respiratory depression. We sometimes refer to this as the ‘sleepy death.'” It can also cause paralysis and seizures. Luckily, nitazene is an “opioid, and naloxone blocks opioids,” said Chinazo Cunningham, the commissioner of the New York State Office of Addiction, Services and Supports, to CBS News. “If it's a very powerful opioid, it may take a couple of doses.”
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Devika Rao has worked as a staff writer at The Week since 2022, covering science, the environment, climate and business. She previously worked as a policy associate for a nonprofit organization advocating for environmental action from a business perspective.
-
Can medical debt hurt your credit?The explainer The short answer is yes, though it depends on the credit scoring mode
-
6 optimal digital nomad destinations. Pack your laptop, your visa and a sense of adventure.The Week Recommends See the world — but do it in a conscientious manner
-
‘The issue isn’t talent but moral guidance’Instant Opinion Opinion, comment and editorials of the day
-
The plant-based portfolio diet invests in your heart’s healthThe Explainer Its guidelines are flexible and vegan-friendly
-
More women are using more testosterone despite limited researchThe explainer There is no FDA-approved testosterone product for women
-
Doctors sound the alarm about insurance company ‘downcoding’The Explainer ‘It’s blatantly disrespectful,’ one doctor said
-
Can TrumpRx really lower drug prices?Today’s Big Question Pfizer’s deal with Trump sent drugmaker stocks higher
-
Kissing bug disease has a growing presence in the USThe explainer The disease has yielded a steady stream of cases in the last 10 years
-
Private equity firms might be causing more deaths in hospital ERsThe Explainer Deaths in ERs purchased by private equity firms rose 13%
-
The UK’s opioid crisis: why the stats don’t add upThe Explainer A new report has revealed that the UK’s total of opioid-related deaths could be much greater than official figures show
-
Sloth fever shows no signs of slowing downThe explainer The vector-borne illness is expanding its range
